← Literature

Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors.

review • 2025 • ID: 40607385

Moderate Confidence Review

Primary source: [Open]

Linked compounds: semaglutideretatrutidebpc-157

Outcomes summary

Review discussing immunogenicity considerations for therapeutic peptide products, including the role of product-related risk factors and impurities in immune responses.

Limitations

Broad overview; does not establish immunogenicity risk for any specific peptide without product- and context-specific data.

Notes

Primary source: PMID 40607385 (see PubMed link on this page).